KB

Kunal Bhavarlal Malvi

Active Director Managing Director DIN 11201626
DIN 11201626 First appointment Jul 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Kunal Bhavarlal Malvi

Data last updated:

Kunal Bhavarlal Malvi is a Managing Director at Aequus Pharma Private Limited (since 2025).

DIN 11201626
Primary Designation Managing Director
First Appointment 18 Jul 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aequus Pharma Private Limited U46497GJ2025PTC165246
Managing Director18 Jul 20252025Active

Board colleagues of Kunal Bhavarlal Malvi

NameDINCompanyDesignation
Kanhaiya Lal06452570Aequus Pharma Private LimitedManaging Director
Raksha Kumari10158265Aequus Pharma Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Aequus Pharma Private Limited
Premium access

Shareholding and investment profile for Kunal Bhavarlal Malvi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kunal Bhavarlal Malvi

Kunal Bhavarlal Malvi currently holds 1 directorship: Aequus Pharma Private Limited (Managing Director, since 18 Jul 2025).

Kunal Bhavarlal Malvi was first appointed on 18 Jul 2025 as Managing Director at Aequus Pharma Private Limited.

The current boards of Kunal Bhavarlal Malvi's companies include Kanhaiya Lal (Aequus Pharma Private Limited), Raksha Kumari (Aequus Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available